Ethyl (1E)-N-cyanoethanimidate

We are Ethyl (1E)-N-cyanoethanimidate CAS:1558-82-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 1558-82-3
Product Name: Ethyl (1E)-N-cyanoethanimidate
Other Name:
Ethyl (1E)-N-cyanoethanimidate
Cyano Ethyl Acetamidate
(E)-Ethyl N-cyanoacetimidate
Ethyl N-cyanoacetoimidate
N-Cyanoethanimidic ethyl ester
Ethyl (1Z)-N-cyanoethanimidoate
N-Cyanacetimidsaeure-ethylester
 
Density: 0.9±0.1 g/cm3
Boiling Point: 133.2±23.0 °C at 760 mmHg
Molecular Formula: C5H8N2O
Molecular Weight: 112.130
Flash Point: 34.4±22.6 °C
Exact Mass: 112.063660
PSA: 45.38000
LogP: 0.86
Vapour Pressure: 8.6±0.2 mmHg at 25°C
Index of Refraction: 1.444
 
Specification
Appearance: Colorless transparent liquid
Assay: ≥99.0%
Water: ≤0.03%
Loss on drying: ≤0.10%
 
Application
Intermediates of Acetaniprid CAS: 135410-20-7.
Be used as pesticide intermediate, mainly used in the synthesis of the insecticide Acetaniprid.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Ethyl (1E)-N-cyanoethanimidate


Related News: Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.6,6-dimethylhept-1-en-4-yn-3-ol CAS:78629-20-6 In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.100-00-5 Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.oleic acid Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.

Related Products
Product Name
(4S,5R)-2-(4-methoxyphenyl)-3-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenyl-1,3-oxazolidine-5-carboxylic acid View Details
2,3-dichloro-5-fluoropyridine View Details
2′-(Trifluoromethyl)acetophenone View Details
2-(5-Chloro-2-Benzotriazolyl)-6-Tert-Butyl-p-Cresol manufacturer 9-Bromo-10-(1-Naphthalenyl)Anthracene manufacturer 4,4′-Dibromo-4”-phenyltriphenylamine manufacturer 1-chloro-9-iodononane manufacturer Palmitoyl Hexapeptide-12 manufacturer